Core Points - BioNTech SE will announce its financial results for Q1 2025 on May 5, 2025, and will host a conference call and webcast at 8:00 a.m. EDT [1] - The conference call will be accessible via telephone registration, and participants are encouraged to register at least one day in advance [2] - A replay of the webcast will be available shortly after the call and archived for 30 days on the company's website [3] Company Overview - BioNTech is a global next-generation immunotherapy company focused on developing novel therapies for cancer and serious diseases [4] - The company utilizes a variety of computational discovery and therapeutic drug platforms for rapid biopharmaceutical development [4] - BioNTech's oncology product candidates include mRNA cancer immunotherapies, immunomodulators, targeted therapies like antibody-drug conjugates (ADCs), and CAR T cell therapies [4] - The company is also developing multiple mRNA vaccine candidates for infectious diseases, leveraging its expertise in mRNA development and manufacturing [4] - BioNTech has established collaborations with various global pharmaceutical companies, including Pfizer, Genentech, and Regeneron [4]